The 2nd FOSTER Conference, supported by The Bardo Foundation, aimed to improve the outcomes for osteosarcoma patients, focusing on the duration and quality of life. The event fostered multidisciplinary interactions, encouraging early drug development and collaborative translational research. It also emphasized the importance of clinical research in therapies, exchange programs for young investigators, educational meetings, and participation in clinical trials. The FOSTER Consortium's commitment to data sharing and network harmonization was evident, aligning with the foundation's mission to advance research and treatment in osteosarcoma.
For more detailed information about the conference, please visit - FOSTER Consortium.
For more detailed information about the conference, please visit - FOSTER Consortium.
Leave a comment